Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Short communication: enhancement of immunogenicity of replication-defective adenovirus-based human immunodeficiency virus vaccines in rhesus monkeys.

Sun C, Zhang Y, Liu Y, Zhang M, Chen L.

AIDS Res Hum Retroviruses. 2011 Jun;27(6):681-6. doi: 10.1089/AID.2010.0210. Epub 2011 Jan 8. Review.

PMID:
21083437
2.

Adenoviruses as vectors for HIV vaccines.

Gómez-Román VR, Robert-Guroff M.

AIDS Rev. 2003 Jul-Sep;5(3):178-85. Review.

PMID:
14598567
3.

Development of a DNA-MVA/HIVA vaccine for Kenya.

Hanke T, McMichael AJ, Mwau M, Wee EG, Ceberej I, Patel S, Sutton J, Tomlinson M, Samuel RV.

Vaccine. 2002 May 6;20(15):1995-8. Review.

PMID:
11983261
4.

Development of a Sendai virus vector-based AIDS vaccine inducing T cell responses.

Seki S, Matano T.

Expert Rev Vaccines. 2016;15(1):119-27. doi: 10.1586/14760584.2016.1105747. Epub 2015 Oct 29. Review.

PMID:
26512881
5.

Development of replication-competent viral vectors for HIV vaccine delivery.

Parks CL, Picker LJ, King CR.

Curr Opin HIV AIDS. 2013 Sep;8(5):402-11. doi: 10.1097/COH.0b013e328363d389. Review.

6.

Delivery of antigens by viral vectors for vaccination.

Krause A, Worgall S.

Ther Deliv. 2011 Jan;2(1):51-70. Review.

PMID:
22833925
7.

Ebola virus vaccine: benefit and risks of adenovirus-based vectors.

Mennechet FJ, Tran TT, Eichholz K, van de Perre P, Kremer EJ.

Expert Rev Vaccines. 2015;14(11):1471-8. doi: 10.1586/14760584.2015.1083429. Epub 2015 Aug 31. Review.

PMID:
26325242
8.

Nonreplicating vectors in HIV vaccines.

Johnson JA, Barouch DH, Baden LR.

Curr Opin HIV AIDS. 2013 Sep;8(5):412-20. doi: 10.1097/COH.0b013e328363d3b7. Review.

9.

Adenovirus-based genetic vaccines for biodefense.

Boyer JL, Kobinger G, Wilson JM, Crystal RG.

Hum Gene Ther. 2005 Feb;16(2):157-68. Review.

PMID:
15761256
10.

Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development.

Patterson LJ, Robert-Guroff M.

Expert Opin Biol Ther. 2008 Sep;8(9):1347-63. doi: 10.1517/14712598.8.9.1347 . Review.

11.

Adenovirus vector-based vaccines for human immunodeficiency virus type 1.

Barouch DH, Nabel GJ.

Hum Gene Ther. 2005 Feb;16(2):149-56. Review.

PMID:
15761255
12.

New insights on adenovirus as vaccine vectors.

Lasaro MO, Ertl HC.

Mol Ther. 2009 Aug;17(8):1333-9. doi: 10.1038/mt.2009.130. Epub 2009 Jun 9. Review.

13.

Challenges in manufacturing adenoviral vectors for global vaccine product deployment.

Vellinga J, Smith JP, Lipiec A, Majhen D, Lemckert A, van Ooij M, Ives P, Yallop C, Custers J, Havenga M.

Hum Gene Ther. 2014 Apr;25(4):318-27. doi: 10.1089/hum.2014.007. Epub 2014 Apr 2. Review.

PMID:
24593243
14.

Viral vectors as vaccine carriers.

Ertl HC.

Curr Opin Virol. 2016 Dec;21:1-8. doi: 10.1016/j.coviro.2016.06.001. Epub 2016 Jun 18. Review.

PMID:
27327517

Supplemental Content

Support Center